iZafe Group AB (publ) (IZAFE-B.ST)
SEK 0.25
(-2.34%)
SEK 0.25
(-2.34%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 279 Thousand SEK | -90.24% |
| 2022 | 2.86 Million SEK | -26.55% |
| 2021 | 3.89 Million SEK | 0.0% |
| 2020 | - SEK | -100.0% |
| 2019 | 4.15 Million SEK | 253.19% |
| 2018 | 1.17 Million SEK | 213.33% |
| 2017 | 375 Thousand SEK | -61.54% |
| 2016 | 975 Thousand SEK | -23.53% |
| 2015 | 1.27 Million SEK | -33.73% |
| 2014 | 1.92 Million SEK | 38.64% |
| 2013 | 1.38 Million SEK | 197.69% |
| 2012 | 466.15 Thousand SEK | 74.36% |
| 2011 | 267.35 Thousand SEK | -60.49% |
| 2010 | 676.73 Thousand SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.59 Million SEK | 0.0% |
| 2024 Q2 | 828 Thousand SEK | -41.4% |
| 2024 Q3 | 308 Thousand SEK | 41.28% |
| 2023 Q2 | 2.01 Million SEK | -21.22% |
| 2023 Q4 | 279 Thousand SEK | -84.08% |
| 2023 Q3 | 1.75 Million SEK | -12.92% |
| 2023 FY | 279 Thousand SEK | -90.24% |
| 2023 Q1 | 2.55 Million SEK | -10.7% |
| 2022 Q3 | 2.78 Million SEK | -7.62% |
| 2022 FY | 2.86 Million SEK | -26.55% |
| 2022 Q1 | 3.61 Million SEK | -7.16% |
| 2022 Q2 | 3.01 Million SEK | -16.54% |
| 2022 Q4 | 2.86 Million SEK | 2.62% |
| 2021 Q1 | 1.33 Million SEK | 0.0% |
| 2021 FY | 3.89 Million SEK | 0.0% |
| 2021 Q4 | 3.89 Million SEK | -1.62% |
| 2021 Q3 | 3.95 Million SEK | -10.88% |
| 2021 Q2 | 4.44 Million SEK | 233.66% |
| 2020 Q4 | - SEK | 0.0% |
| 2020 Q1 | 6.04 Million SEK | 45.59% |
| 2020 Q2 | 3.75 Million SEK | -37.93% |
| 2020 Q3 | - SEK | -100.0% |
| 2020 FY | - SEK | -100.0% |
| 2019 Q3 | 4.3 Million SEK | -6.48% |
| 2019 FY | 4.15 Million SEK | 253.19% |
| 2019 Q4 | 4.15 Million SEK | -3.49% |
| 2019 Q1 | 1.54 Million SEK | 31.49% |
| 2019 Q2 | 4.59 Million SEK | 197.61% |
| 2018 Q4 | 1.17 Million SEK | -29.85% |
| 2018 FY | 1.17 Million SEK | 213.33% |
| 2018 Q2 | 1.75 Million SEK | 438.46% |
| 2018 Q3 | 1.67 Million SEK | -4.29% |
| 2018 Q1 | 325 Thousand SEK | -13.33% |
| 2017 FY | 375 Thousand SEK | -61.54% |
| 2017 Q1 | 900 Thousand SEK | -7.69% |
| 2017 Q2 | 825 Thousand SEK | -8.33% |
| 2017 Q3 | 775 Thousand SEK | -6.06% |
| 2017 Q4 | 375 Thousand SEK | -51.61% |
| 2016 Q2 | 1.09 Million SEK | 0.0% |
| 2016 Q4 | 975 Thousand SEK | 0.0% |
| 2016 FY | 975 Thousand SEK | -23.53% |
| 2016 Q1 | - SEK | -100.0% |
| 2015 Q1 | 1.45 Million SEK | -24.41% |
| 2015 FY | 1.27 Million SEK | -33.73% |
| 2015 Q4 | 1.27 Million SEK | 0.0% |
| 2015 Q3 | 1.27 Million SEK | -12.32% |
| 2015 Q2 | 1.45 Million SEK | 0.0% |
| 2014 Q3 | 1.92 Million SEK | 6.13% |
| 2014 Q1 | 1.35 Million SEK | -2.44% |
| 2014 Q2 | 1.81 Million SEK | 33.9% |
| 2014 FY | 1.92 Million SEK | 38.64% |
| 2014 Q4 | 1.92 Million SEK | 0.0% |
| 2013 Q1 | 746.9 Thousand SEK | 60.23% |
| 2013 Q4 | 1.38 Million SEK | 13.55% |
| 2013 Q3 | 1.22 Million SEK | 21.66% |
| 2013 Q2 | 1 Million SEK | 34.5% |
| 2013 FY | 1.38 Million SEK | 197.69% |
| 2012 FY | 466.15 Thousand SEK | 74.36% |
| 2012 Q3 | 51.01 Thousand SEK | 0.0% |
| 2012 Q4 | 466.15 Thousand SEK | 813.81% |
| 2011 FY | 267.35 Thousand SEK | -60.49% |
| 2010 FY | 676.73 Thousand SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AddLife AB (publ) | 2.53 Billion SEK | 99.989% |
| Biotage AB (publ) | 150 Million SEK | 99.814% |
| Bonesupport Holding AB (publ) | 13.22 Million SEK | 97.89% |
| Doxa AB (publ) | 3.6 Million SEK | 92.25% |
| Elekta AB (publ) | 4.8 Billion SEK | 99.994% |
| Ortivus AB (publ) | 3.57 Million SEK | 92.194% |
| Ortivus AB (publ) | 3.57 Million SEK | 92.194% |
| Q-linea AB (publ) | 12.9 Million SEK | 97.838% |
| S2Medical AB (publ) | - SEK | -Infinity% |
| Synsam AB (publ) | 2.02 Billion SEK | 99.986% |